Efficacy and Safety of Clearing Heat and Detoxifying Injection in the Treatment of Influenza: A Randomized, Double-Blinded, Placebo-Controlled Trial

Table 2

Duration of fever symptom in CHDI and Oseltamivir groups.

	Influenza-infected participants		All treated participants
	CHDI; ()	Oseltamivir; ()	CHDI; ()	Oseltamivir; ()
Fever alleviation time,; (~), h^※	2.5; (1.53)	5; (3.510)	2; (13)	6; (38)
HR, (95% CI)/	0.52 (0.25, 1.08)/0.07^#		0.47 (0.36, 0.61)/0.001^#
Fever clearance time,; (~), h	32.5; (17.552)	49; (32.281)	29; (1846)	49; (33.569)
HR, (95% CI)/	0.69 (0.34, 1.43)/0.32^#		0.64 (0.49, 0.83)/0.001^#

indicates the median time. and indicate lower quartile and upper quartile. ^#HR < 1, but indicates that fever alleviation and clearance time are less in CHDI than in Oseltamivir, but no statistical differences were shown.